Brain Heart InterActioNs in Cardiac Arrest. Ancillary Study of the HEAVENwARd Trial
NCT ID: NCT06327334
Last Updated: 2025-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2024-11-25
2027-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This ancillary study of a multicentre prospective cohort "HEAVENwARd study" (NCT06044922) will assess the prevalence and prognostic value of bilateral brain-heart interactions in comatose patients after CA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early DiaGnosis of Anoxic Brain Injury for Resuscitated Patients
NCT03806660
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
NCT06387225
Multimodal Assessment of the Neurological Prognosis of Patients With Brain Lesions on ExtraCorporeal Life Support
NCT03633981
Prediction of Delayed Cognitive Impairment in Cardiac Arrest Survivors With Good Neurological Outcomes
NCT05830422
Evaluation of Prognosis Factors of Neurological Evolution in Cardiac Arrest
NCT02849561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients included in the HEAVENwARd study who have an EEG with ECG lead recorded for a neuroprognostication are eligible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Coma (Glasgow score \< 8) after ROSC, requiring sedation and targeted temperature management for at least 24h
* EEG with ECG lead performed in routine care
Exclusion Criteria
* Limitation of life sustaining treatment before EEG
* Non-Sinus Rhythm
* Pregnant or breastfeeding women
* Patient under protection of the adults (guardianship, curators or safeguard of justice)
* Opposition by the trusted person or by the patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CMC Ambroise Paré
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brest University Hospital
Brest, Brittany Region, France
Nantes University Hospital
Nantes, Pays de la Loire Region, France
Marseille University Hospital
Marseille, Provence-Alpes-Côte d'Azur Region, France
Ambroise Paré - Hartmann Private Hospital Group
Neuilly-sur-Seine, Île-de-France Region, France
Cochin Hospital
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.